These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

770 related items for PubMed ID: 25201211

  • 1. Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers.
    Tandoi F, Caviglia GP, Pittaluga F, Abate ML, Smedile A, Romagnoli R, Salizzoni M.
    Dig Liver Dis; 2014 Nov; 46(11):1020-4. PubMed ID: 25201211
    [Abstract] [Full Text] [Related]

  • 2. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 3. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
    Caviglia GP, Abate ML, Tandoi F, Ciancio A, Amoroso A, Salizzoni M, Saracco GM, Rizzetto M, Romagnoli R, Smedile A.
    J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
    [Abstract] [Full Text] [Related]

  • 4. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [Abstract] [Full Text] [Related]

  • 5. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A.
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [Abstract] [Full Text] [Related]

  • 6. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [Abstract] [Full Text] [Related]

  • 7. Anti-HBc-positive/HBsAg-negative liver donors pose a higher risk of occult HBV infection but do not cause severe histological damage in liver grafts.
    Niu Y, Chen X, Feng L, You H, Ren X, Liu H, Zheng J, Shen Z, Jia J.
    Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):475-80. PubMed ID: 24835492
    [Abstract] [Full Text] [Related]

  • 8. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
    Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A.
    Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
    [Abstract] [Full Text] [Related]

  • 9. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, Bock CT, Kremsner PG, Velavan TP.
    PLoS One; 2015 Apr; 10(7):e0131912. PubMed ID: 26148052
    [Abstract] [Full Text] [Related]

  • 10. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [Abstract] [Full Text] [Related]

  • 11. De novo and apparent de novo hepatitis B virus infection after liver transplantation.
    Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, David MF, Arulnaden JL, Bismuth A, Reynes M, Bismuth H.
    J Hepatol; 1997 Mar; 26(3):517-26. PubMed ID: 9075658
    [Abstract] [Full Text] [Related]

  • 12. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [Abstract] [Full Text] [Related]

  • 13. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators.
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [Abstract] [Full Text] [Related]

  • 14. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 15. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC.
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [Abstract] [Full Text] [Related]

  • 16. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP.
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC.
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 19. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z, Milani S, Sharifi Z.
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [Abstract] [Full Text] [Related]

  • 20. Occult hepatitis B virus infection.
    Allain JP.
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.